RM
ResMed Inc.
RMD.AX · ASX
$31.41 +0.06% (+$0.02)
1M +5.28%
Market Cap $32.9B
P/E Ratio 21.67x
Div. Yield -
ROE 23.74%
Bulios Fair Price
$26.6
15.3% downside
Trenutna cena
$31.41
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RMD.AX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
51 /100
Fair P/FCF 20.03x
P/S 5.84x
P/B 5.00x
Growth
89 /100
Growing Rev. growth 11.01%
FCF growth 44.45%
Book val. growth 16.81%
Profitability
100 /100
Strong Net margin 26.95%
Op. margin 33.75%
FCF margin 29.16%
Quality
92 /100
Excellent ROE 23.74%
ROA 16.93%
Asset turnover 0.63x
Debt
100 /100
Low Current ratio 3.10x
Int. coverage 216.59x
Net debt/EBITDA -0.30x
Stability
100 /100
Stable Rev. volatility 1.21%
EPS volatility 12.89%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RMD.AX
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael J. Farrell
Employees
11,370
Headquarters
San Diego
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report